Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Sutton

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Neuroscience Methods|August 29, 2006
Localized gene expression of axon guidance molecules in neuronal co-culturesP M Heron, B M Sutton, G M Curinga, et al.
Journal of Medicinal Chemistry|June 1, 1979
Application of quantitative structure-activity relationships in the development of the antiallergic pyranenaminesR D Cramer, K M Snader, C R Willis, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicityM A Naylor, B M Sutton, J Nolan, et al.
Journal of Medicinal Chemistry|January 1, 1984
Antiinflammatory activity of 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles. Isomeric 4-pyridyl and 4-substituted phenyl derivativesI Lantos, P E Bender, K A Razgaitis, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1997
Metabolism of the calcium antagonist, mibefradil (POSICOR, Ro 40-5967). Part II. Metabolism in hepatic microsomes from rat, marmoset, cynomolgus monkey, rabbit and manH R Wiltshire, B M Sutton, G Heeps, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Pharmacokinetics, metabolism and distribution of 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-A] pyrido [3,2-E] pyrazine-5-oxide in C3H miceB M Sutton, N J Reeves, M A Naylor, et al.
Research Communications in Chemical Pathology and Pharmacology|August 1, 1975
Inhibition of prostaglandin synthetase and carrageenan-induced edema by tricyclic analogs of flufenamic acidJ W Horodniak, E D Matz, D T Walz, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1997
Metabolism of the calcium antagonist, mibefradil (POSICOR, Ro 40-5967). Part III. Comparative pharmacokinetics of mibefradil and its major metabolites in rat, marmoset, cynomolgus monkey and manH R Wiltshire, B M Sutton, G Heeps, et al.
Journal of Medicinal Chemistry|September 1, 1985
5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agentsP E Bender, D T Hill, P H Offen, et al.
Journal of Medicinal Chemistry|June 1, 1979
Pyranenamines: a new series of antiallergic compoundsK M Snader, L W Chakrin, R D Cramer, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Neuroscience Methods|August 29, 2006
Localized gene expression of axon guidance molecules in neuronal co-culturesP M Heron, B M Sutton, G M Curinga, et al.
Journal of Medicinal Chemistry|June 1, 1979
Application of quantitative structure-activity relationships in the development of the antiallergic pyranenaminesR D Cramer, K M Snader, C R Willis, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicityM A Naylor, B M Sutton, J Nolan, et al.
Journal of Medicinal Chemistry|January 1, 1984
Antiinflammatory activity of 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles. Isomeric 4-pyridyl and 4-substituted phenyl derivativesI Lantos, P E Bender, K A Razgaitis, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1997
Metabolism of the calcium antagonist, mibefradil (POSICOR, Ro 40-5967). Part II. Metabolism in hepatic microsomes from rat, marmoset, cynomolgus monkey, rabbit and manH R Wiltshire, B M Sutton, G Heeps, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Pharmacokinetics, metabolism and distribution of 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-A] pyrido [3,2-E] pyrazine-5-oxide in C3H miceB M Sutton, N J Reeves, M A Naylor, et al.
Research Communications in Chemical Pathology and Pharmacology|August 1, 1975
Inhibition of prostaglandin synthetase and carrageenan-induced edema by tricyclic analogs of flufenamic acidJ W Horodniak, E D Matz, D T Walz, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1997
Metabolism of the calcium antagonist, mibefradil (POSICOR, Ro 40-5967). Part III. Comparative pharmacokinetics of mibefradil and its major metabolites in rat, marmoset, cynomolgus monkey and manH R Wiltshire, B M Sutton, G Heeps, et al.
Journal of Medicinal Chemistry|September 1, 1985
5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agentsP E Bender, D T Hill, P H Offen, et al.
Journal of Medicinal Chemistry|June 1, 1979
Pyranenamines: a new series of antiallergic compoundsK M Snader, L W Chakrin, R D Cramer, et al.
Pageof 3